Abritiga 250mg Tablet
bottle of 120.0 tablets.Prescription required
About this product:
| Salt Composition: | Abiraterone Acetate (250mg) |
| Manufacturer: | Zee Laboratories |
| Storage: | Below 25 degree celcius |
Out of Stock
Have doubts about this medicine?
Have doubts about this medicine?
Abritiga 250mg Tablet is used in the treatment of cancer of the prostate gland. Abritiga 250mg Tablet is used in the treatment of cancer of the prostate gland. It may be also used to treat other conditions, as determined by the doctor. It is sometimes used with certain other medicines as part of combination chemotherapy.
Abritiga 250mg Tablet is an anticancer medication. It works by preventing androgen (male hormone) production in man. This is done by inhibiting an enzyme (CYP17) that is responsible for the production of androgen. This is how it slows down the growth of prostate cancer.
Can Abritiga 250mg Tablet cure prostate cancer?
Abritiga 250mg Tablet is a hormonal treatment and does not cure cancer. It helps to prolong and improve the quality of life for individuals with advanced prostate cancer. The medication also helps reduce the frequency of fractures and minimizes pain increase.
Is Abritiga 250mg Tablet a chemotherapy drug?
Abritiga 250mg Tablet is a hormonal therapy, not a chemotherapy drug. It is used to treat advanced prostate cancer in adult men whose cancer has spread to other parts of the body. This medication stops your body from producing testosterone, slowing down the growth of prostate cancer cells.
Why do I need to take prednisolone with Abritiga 250mg Tablet?
Prednisolone is prescribed in conjunction with Abritiga 250mg Tablet. Combining these two medicines helps to lower the risk of high blood pressure, fluid retention (extra water in the body), and reduced potassium levels which may occur due to Abritiga 250mg Tablet.
Does Abritiga 250mg Tablet affect my liver?
Abritiga 250mg Tablet can cause severe liver problems. Rare cases, Abritiga 250mg Tablet may even lead to the liver ceasing to function completely (called acute liver failure), which can be life-threatening. Tell your doctor immediately if you experience symptoms such as yellowing of the skin or eyes, changes in urine color, or severe nausea and vomiting. These could indicate a problem with your liver.
How often should I have my liver checked?
Before starting treatment, liver enzymes should be measured. Subsequently, testing should occur every two weeks for the first three months of treatment and monthly thereafter. If you experience clinical symptoms suggestive of liver toxicity, liver enzyme tests need to be performed immediately. If your liver enzyme levels rise beyond certain levels, your doctor may temporarily discontinue Abritiga 250mg Tablet.
How do I take Abritiga 250mg Tablet?
Abritiga 250mg Tablet should be taken on an empty stomach with water, one hour before eating or at least two hours after eating. Taking it with food may cause high levels of the medication in your blood, which could be harmful. It is crucial to avoid crushing or chewing the tablet.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush or break it. Abritiga 250mg Tablet is to be taken empty stomach.
- Treats prostate cancer that has spread to other parts of the body.
- Usually taken with another medicine called prednisolone to reduce unwanted side effects.
- Must be taken on an empty stomach.
- Always use effective birth control measures to prevent pregnancy while taking this medicine.
- Your doctor may regularly monitor your liver function, blood pressure, and the level of potassium in your blood while you are having treatment with this medicine.
Alcohol
It is not known whether it is safe to consume alcohol with Abritiga 250mg Tablet. Please consult your doctor.
Breastfeed
Abritiga 250mg Tablet is unsafe to use during breastfeeding. Data suggests that the drug may cause toxicity to the baby.
Pregnancy
Abritiga 250mg Tablet is highly unsafe to use during pregnancy. Seek your doctor's advice as studies on pregnant women and animals have shown significant harmful effects to the developing baby.
